Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Choroideremia carriers maintain a normal electro-oculogram (EOG).

Ryan J Yau1, Christina A Sereda, Kerry E McTaggart

  • 1Ocular Genetics Laboratory, University of Alberta, Edmonton, AB, Canada.

Documenta Ophthalmologica. Advances in Ophthalmology
|March 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plagl1 regulates the retinal progenitor cell to Müller glial cell transition.

PLoS genetics·2026
Same author

Identification of Two Novel Mutations in the CHM Gene Causing Choroideremia.

American journal of medical genetics. Part A·2026
Same author

PIKfyve is an essential component of the endolysosomal pathway within photoreceptors and the retinal pigment epithelium.

Experimental eye research·2026
Same author

RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals.

Investigative ophthalmology & visual science·2025
Same author

RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals.

Research square·2025
Same author

Genetic Analysis of Choroideremia-Related Rab Escort Proteins.

International journal of molecular sciences·2025

Choroideremia (CHM) carriers with REP-1 gene mutations maintain normal visual acuity and EOG Arden ratios, despite fundus degeneration. This indicates preserved retinal function in female carriers across a range of ages.

Area of Science:

  • Ophthalmology
  • Genetics
  • Retinal Diseases

Background:

  • Choroideremia (CHM) is an X-linked genetic disorder affecting the retina.
  • Female carriers of CHM mutations may exhibit fundus changes but typically retain normal visual acuity.
  • Assessing retinal function in CHM carriers is crucial for understanding disease progression and carrier status.

Purpose of the Study:

  • To evaluate the functional integrity of the retinal pigment epithelium and outer retina in female choroideremia carriers.
  • To correlate confirmed REP-1 gene mutations with objective electrophysiological measurements.
  • To determine if electroretinography (EOG) can detect functional deficits in CHM carriers.

Main Methods:

  • Seventeen female choroideremia carriers (ages 25-61) underwent visual acuity testing and EOG recordings.

Related Experiment Videos

  • DNA analysis involved PCR amplification and sequencing of the 15 exons of the CHM gene to identify mutations.
  • Fundus examinations were performed to document characteristic chorioretinal degeneration.

    • Main Results:

    • All 17 carriers possessed normal visual acuity (average logMAR 0.07, equivalent to 20/25).
    • The average EOG Arden ratio was 2.71, not statistically different from the control average of 2.46.
    • Genetic sequencing confirmed CHM gene mutations in all participants, and funduscopy showed signs consistent with carrier status.

    Conclusions:

    • Female choroideremia carriers with REP-1 mutations do not exhibit altered EOG Arden ratios within the studied age range (25-61 years).
    • Despite observable fundus degeneration, electrophysiological assessment suggests preserved retinal function in these carriers.
    • The EOG may not be sensitive enough to detect subtle functional changes in CHM carriers over time.